MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/iop.0b013e3182873d7d

Медицинская библиотека · Ophthalmic plastic and reconstructive surgery · 2013

Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A.

McElhinny Elaine R, Reich Isaac, Burt Benjamin, Mancini Ronald, Wladis Edward J, Durairaj Vikram D, Shinder Roman

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

PURPOSE: To report on low-dose minimal injection treatment using botulinum toxin A for pseudoptosis secondary to aberrant facial nerve regeneration.

METHODS

A retrospective chart review was carried out on 16 consecutive patients with pseudoptosis secondary to aberrant facial nerve regeneration who received botulinum toxin A injections.

RESULTS

Study patients include 6 men and 10 women with median age of 65 years (range 34-78). Etiology of facial nerve palsy included Bell palsy (11), surgical injury (2), trauma (2), and Ramsay-Hunt syndrome (1). Mean duration of facial nerve palsy was 8.5 years (1.1-30). Mean duration of pseudoptosis was 6.8 years (0.5-29). Botulinum toxin A (Botox; Allergan) injections were given in the medial and lateral pretarsal upper eyelid orbicularis oculi with some patients also receiving a central and/or additional lateral injection. Mean number of injections was 2.6 (2-4). Mean total dose was 10.3 units (5-20). Subjective improvement of symptoms at follow up was noted in all cases. Margin reflex distance in all patients showed statistically significant (p < 0.001) mean improvement of 1.6 mm (0.5-2.5) during orbicularis oris contracture. No side effects were reported, and all patients desired repeat injections. Repeat injection was performed at 3- to 6-month intervals, with most patients (12) returning every 3 months. Mean follow up was 12.2 months (3-61).

CONCLUSIONS

Using low doses of carefully injected botulinum toxin A into the upper eyelid can provide safe and successful treatment of pseudoptosis due to aberrant facial nerve regeneration.

Для цитирования: McElhinny Elaine R, Reich Isaac, Burt Benjamin, Mancini Ronald, Wladis Edward J, Durairaj Vikram D, Shinder Roman. Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A.. Ophthalmic plastic and reconstructive surgery. 2013. DOI: 10.1097/iop.0b013e3182873d7d.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.